What's new

Human medicines European public assessment report (EPAR): Edurant, rilpivirine, Date of authorisation: 28/11/2011, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Edurant, rilpivirine, Date of authorisation: 28/11/2011, Revision: 22, Status: Authorised

Apr 11, 2025 - 15:46
 0
Human medicines European public assessment report (EPAR): Edurant, rilpivirine, Date of authorisation: 28/11/2011, Revision: 22, Status: Authorised
Human medicines European public assessment report (EPAR): Edurant, rilpivirine, Date of authorisation: 28/11/2011, Revision: 22, Status: Authorised
Read More

Tags:

Previous Article

As Pfizer backs out of hemophilia gene therapy space, CSL hopes Hemgenix is here...

Next Article

Mytheresa secures regulatory clearance for YNAP acquisition

Related Posts

List of withdrawn medicinal products in accordance with...

Mar 7, 2025  0

European Shortages Monitoring Platform (ESMP) training on crisis and MSSG-led preparedness reporting for marketing authorisation holders (MAHs), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 19 February 2025, 10:00 (CET) to 19 February 2025, 12:30 (CET)

European Shortages Monitoring Platform (ESMP) training ...

Mar 13, 2025  0

Human medicines European public assessment report (EPAR): Loqtorzi, Toripalimab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 8, 2025  0